The PROGRESS trial three years later: time for a balanced report of effectiveness

AUTOR(ES)

Wennberg, Richard

FONTE

BMJ Publishing Group Ltd.

RESUMO

Has the use of the phrase “perindopril based blood pressure lowering regimen” resulted in an oversimplistic and hence inaccurate interpretation of the results of the PROGRESS trial creeping into the literature and clinical practice?

Documentos Relacionados

• The PROGRESS trial three years later: time for more action, less distraction
• The PROGRESS trial three years later: time for more action, less distraction (commentary)
• The PROGRESS trial three years later: Evangelism is understandable
• The PROGRESS trial three years later: HOPE trial may shed some light
• The PROGRESS trial three years later: Clear and accurate interpretations of studies are needed